Investigation
Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Menu
Investigation
03/17/2021
Initial Lawsuit
03/17/2021
Lawsuit Progression
08/19/2021
This is a federal securities action on behalf of a class consisting of all persons who purchased or otherwise acquired CytoDyn common stock between March 27, 2020, and March 9, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) deceive the investing public, including Plaintiff and other Class members, as alleged herein;
(ii) artificially inflate and maintain the market price of CytoDyn securities;
(iii) cause Plaintiff and other members of the Class to purchase or otherwise acquire CytoDyn securities at artificially inflated prices.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.